The AfriDx project is investigating the potential reliability of an isothermal nucleic acid testing system for the clinical diagnosis of COVID-19 and (later) other infectious diseases in Africa and considering how this and other health related diagnostics could be manufactured locally in low and middle income countries.
Diagnostics are typically too expensive for general use for patients in low income countries. So, the key goal of this project is that diagnostics will be developed to enable local manufacturing, even in low resource environments. During the AfriDx project a Loop-mediated isothermal amplification (LAMP) platform for nucleic acid testing has been trialed for Covid-19 testing, with the aim to use this technique as a prototype to develop further, using some novel locally produced biological reagents.
We are now seeking to understand more about the pathway that could lead to locally produced diagnostics in low income countries.
With this questionnaire we are gathering input from Key Opinion Leaders (KOLs) before planning further developments. If you are a:
- Researcher or Technologist
- Manufacturer or Distributor
- Clinician or Healthcare provider
- Regulator or Legislator
- Purchaser of diagnostics
- User of diagnostics
we would like to ask for your help in answering this questionnaire. It will help enormously in understanding the barriers and planning the pathway to locally produced diagnostics in low income countries.
Thank you for contributing to this questionnaire.
The AfriDx consortium
- University of Cambridge
- Noguchi Memorial Institute for Medical Research (NMIMR)
- Kwame Nkrumah University of Science and Technology (KNUST),
- Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR)
- Danish Technical University (DTU)
- Avoma Group
If you have any questions please contact us on
afridx@ceb.cam.ac.uk